Stock comparison
Eli Lilly
Waters
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$946.37B
Sector
Healthcare
WAT
Waters
Market cap
$22.69B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | WAT | Winner |
|---|---|---|---|
| Warren Buffett | 65B | 57C | LLY |
| Benjamin Graham | 76B | 56C | LLY |
| Philip Fisher | 75B | 54C | LLY |
| Peter Lynch | 64C | 15F | LLY |
| Joel Greenblatt | 68B | 42D | LLY |
| Charlie Munger | 75B | 59C | LLY |
| Terry Smith | 66B | 53C | LLY |
Side-by-side metrics
| Metric | LLY | WAT |
|---|---|---|
| Market cap | $946.37B | $22.69B |
| P/E (TTM) | 35.6x | 63.6x |
| EV/EBIT | 33.2x | 30.7x |
| ROIC (TTM) | 32.06% | 2.25% |
| Gross margin | 83.51% | 55.02% |
| Net margin | 34.98% | 11.91% |
| Revenue CAGR 5y | 23.17% | 3.24% |
| EPS CAGR 5y | 40.81% | -1.02% |
| Debt / Equity | 1.4x | 0.3x |
| Dividend yield | 0.64% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- EPS CAGR 5y40.81%vs -1.02%+102%
- Dividend yield0.64%vs 0.0%+100%
- Market cap$946.37Bvs $22.69B+98%
- ROIC (TTM)32.06%vs 2.25%+93%
WAT leads on
- Debt / Equity0.3xvs 1.4x+75%
- EV/EBIT30.7xvs 33.2x+7%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.